← Back to headlines
Astellas Pharma and Siemens Energy Reaffirm Financial Outlooks
Astellas Pharma reported GAAP EPS of ¥78.96 and revenue of ¥640.91B, reaffirming its FY 2027 outlook. Siemens Energy AG also reaffirmed its FY2026 outlook after reporting GAAP EPS of €1.26 and revenue of €11.45B.
5 Aug, 06:38 — 5 Aug, 06:38
Sources
Showing 1 of 1 sources
